LexDanaLexDanabeta
Inventor

David R. Brittelli

Inventor
Branford, CT, US

Overview

25→
Patents
1976–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds37%
C07CAcyclic or carbocyclic compounds21%
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
PatentTitleYear
8,426,424'Certain substituted amides, method of making, and method of use thereof'20138,222,421'Certain substituted ureas, as modulators of kinase activity'20127,947,835'Certain substituted amides, method of making, and method of use thereof'20117,777,040'Certain substituted ureas, as modulators of kinase activity'20106,911,449'Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids'20056,762,184'Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids'20046,541,468'Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer'20036,500,847'Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids'20026,353,006'Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents'20026,288,063'Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors'20016,225,314'Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids'20016,166,082'Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors'20006,013,646'Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer'20005,932,577'Substituted oxobutyric acids as matrix metalloprotease inhibitors'19995,925,637'Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids'19995,863,915'Substituted 4-arylbutyric acid derivatives as matrix metalloprotease'19995,861,427'Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors'19995,859,047'Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors'19995,854,277'Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors'19985,789,434'Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors'19984,977,173'Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents'19904,877,892'Chiral glycidyl azides as synthetic intermediates to optically active compounds'19894,650,609'Tetraphosphinylquinodimethanes'19874,307,232'Preparation of dialkyl- and diarylphosphonoalkanoic acids and substituted acrylic acids'19813,950,329'Fluorinated cephalosporins'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1990Patents assigned to DU PONT (5)· patent assignee history
1976Based in Wilmington, DE, US· patent location history
1981–1990Based in Nottingham, PA, US· patent location history
1998–2003Patents assigned to BAYER AG (13)· patent assignee history
1998–2013Based in Branford, CT, US· patent location history
2004–2005Patents assigned to BAYER PHARMACEUTICALS CORP (2)· patent assignee history
2010–2013Patents assigned to CGI PHARMACEUTICALS INC (3)· patent assignee history
2012–2013Patents assigned to BLOMGREN PETER A (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG131998–2003
DU PONT51976–1990
CGI PHARMACEUTICALS INC32010–2013
BAYER PHARMACEUTICALS CORP22004–2005
BLOMGREN PETER A22012–2013
Locations
LocationPatentsSpan
Branford, CT, US201998–2013
Nottingham, Pennsylvania, US41981–1990
Wilmington, Delaware, US11976